Roswell Park Cancer Institute Rosewell SC — Buffalo, New York

Roswell Park Cancer Institute Rosewell SC is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute Rosewell SC has participated in 1 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute Rosewell SC?

Roswell Park Cancer Institute Rosewell SC has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute Rosewell SC conducted?

Roswell Park Cancer Institute Rosewell SC has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Is Roswell Park Cancer Institute Rosewell SC accredited by Crixeo Health?

Roswell Park Cancer Institute Rosewell SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute Rosewell SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.